نتایج جستجو برای: druggability

تعداد نتایج: 302  

Journal: :Molecular microbiology 2014
Mariko Dacher Miguel A Morales Pascale Pescher Olivier Leclercq Najma Rachidi Eric Prina Mathieu Cayla Albert Descoteaux Gerald F Späth

Leishmania parasites cause important human morbidity and mortality. Essential Leishmania genes escape genetic assessment by loss-of-function analyses due to lethal null mutant phenotypes, even though these genes and their products are biologically most significant and represent validated drug targets. Here we overcome this limitation using a facilitated null mutant approach applied for the func...

Journal: :Organic & biomolecular chemistry 2015
Zong-Jie Gan Yu-Hua Wang Yun-Gen Xu Ting Guo Jun Wang Qiao Song Xue-Jun Xu Shi-Yuan Hu Yu-Jun Wang De-Chuan Wang De-Zhu Sun Di Zhang Tao Xi Hao-Dong Li Hai-Bo Zhang Tai-Jun Hang Hong-Guo Lu Jing-Gen Liu

A novel series of 1-(pyrrolidin-1-ylmethyl)-2-[(3-oxo-indan)-formyl]-1,2,3,4-tetrahydroisoquinoline derivatives maj-3a-maj-3u were synthesized and evaluated in vitro for their binding affinity at κ-opioid receptors. Maj-3c displayed the highest affinity for κ-opioid receptors (Ki = 0.033 nM) among all the compounds evaluated. Furthermore, all four stereoisomers of compound 3c were prepared, and...

2018
Sindhura Gudipati Ravi Muttineni Archana Uday Mankad Himanshu Aniruddha Pandya Yogesh Trilokinath Jasrai

Noggin (NOG) a BMP (bone morphogenetic protein) antagonist plays a key role in preferentially driving a subset of breast cancer cells towards the bone and causing osteolytic lesions leading to severe pain and discomfort in the patients. Owing to its role in bone metastasis, NOG could be promising molecular target in bone metastasis and that identifying small molecule inhibitors could aid in the...

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2011
Dima Kozakov David R Hall Gwo-Yu Chuang Regina Cencic Ryan Brenke Laurie E Grove Dmitri Beglov Jerry Pelletier Adrian Whitty Sandor Vajda

Despite the growing number of examples of small-molecule inhibitors that disrupt protein-protein interactions (PPIs), the origin of druggability of such targets is poorly understood. To identify druggable sites in protein-protein interfaces we combine computational solvent mapping, which explores the protein surface using a variety of small "probe" molecules, with a conformer generator to accou...

2016
Jeffrey R. Wagner Christopher T. Lee Jacob D. Durrant Robert D. Malmstrom Victoria A. Feher Rommie E. Amaro

Allosteric drug development holds promise for delivering medicines that are more selective and less toxic than those that target orthosteric sites. To date, the discovery of allosteric binding sites and lead compounds has been mostly serendipitous, achieved through high-throughput screening. Over the past decade, structural data has become more readily available for larger protein systems and m...

2014
Thomas S. Dexheimer Andrew S. Rosenthal Diane K. Luci Qin Liang Mark A. Villamil Junjun Chen Hongmao Sun Edward H. Kerns Anton Simeonov Ajit Jadhav Zhihao Zhuang David J. Maloney

Deregulation of ubiquitin conjugation or deconjugation has been implicated in the pathogenesis of many human diseases including cancer. The deubiquitinating enzyme USP1 (ubiquitin-specific protease 1), in association with UAF1 (USP1-associated factor 1), is a known regulator of DNA damage response and has been shown as a promising anticancer target. To further evaluate USP1/UAF1 as a therapeuti...

2010
Hilda David-Eden Alexander S. Mankin Yael Mandel-Gutfreund

The ribosome represents a major target for antibacterial drugs. Being a complex molecular machine, it offers many potential sites for functional interference. The high-resolution structures of ribosome in complex with various antibiotics provide a unique data set for understanding the universal features of drug-binding pockets on the ribosome. In this work, we have analyzed the structural and e...

2015
Shiwei Wang Yao Tong Tzi-Bun Ng Lixing Lao Jenny Ka Wing Lam Kalin Yanbo Zhang Zhang-Jin Zhang Stephen Cho Wing Sze

BACKGROUND Erxian decoction (EXD) is used to treat menopause-related symptoms in Chinese medicine. This study aims to identify the bioactive compounds and potential actions of EXD by network pharmacological analysis. METHODS Two databases, the Traditional Chinese Medicine Systems Pharmacology database and TCM Database@Taiwan, were used to retrieve literature of phytochemicals of EXD. STITCH 4...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید